Navigation Links
Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
Date:12/3/2007

- Screening Determines Efficacy and Safety of Combination Drug Therapies -

HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today launched drug combination services through Caliper Discovery Alliances & Services (CDAS). These new services will help researchers determine the efficacy of combination drug therapies and identify potentially harmful combinations before therapies enter clinical trials. Studies, performed in Caliper's anti-cancer cell proliferation panel, cellular cytokine/chemokine release assays or using in vivo efficacy models, will help identify synergistic responses of drug combinations and eliminate antagonistic mixtures of drugs.

Drug combination studies are increasingly valuable to pre-clinical pharmaceutical research. The simultaneous use of a variety of drugs is common today for the treatment of bacterial infections, HIV, hypertension and cancer. Drug combination testing is subsequently a growing trend in many areas including oncology. If a combination is synergistic, lower doses can be used to achieve the same or better efficacy, which can lead to lower toxicity and safer patient care.

"Drug combination studies using cancer cell lines create a relationship between in vitro screening and profiling, and in vivo animal models. This connection is critical as researchers strive to understand how drug combinations may react in humans," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences. "The exact same cell lines used in the in vitro drug combination testing can be used to create in vivo tumor models to further assess efficacy using the IVIS imaging platform."

The CDAS drug combination studies combine the liquid-handling,
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
7. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...c. 2 Reportlinker.com announces th...s catalogue: ,, EEG/EMG/Brain Function Monito...portlinker.com/p0164319/EEG/EMG/Brain-Function-Mon...ise in obesity, cardiovascular, and autoimmune dis...(EEG) diagnostic and monitoring equipment globally...
(Date:12/2/2009)...c. 2 Reportlinker.com announces th...s catalogue: ,, Cardiovascular Devices: Techn...ortlinker.com/p0166823/Cardiovascular-Devices-Tech...mprehensive view of the cardiovascular devices ind...ew of the major types of cardiovascular diagnostic...
(Date:12/2/2009)...Dec. 2 Cephalon, Inc. (N... lawsuit in U.S. District Court in Delaware agains...of U.S. Patent Nos. 7,132,570 (the ",570 Patent"),...,516 Patent") for the Cephalon product NUVIGIL...hree-year period of marketing exclusivity for NUVI...
Breaking Medicine Technology:Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 2Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 3Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 4Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 5Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 6Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 7Reportlinker Adds EEG/EMG/Brain Function Monitoring - Global Market Trends 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 2Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 3Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 4Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 5Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 6Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 7Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 8Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 9Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 10Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 11Reportlinker Adds Cardiovascular Devices: Technologies and Global Markets 12Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 2Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 3Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals 4New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 1New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 2New Kodak Training Facility Showcases the Latest in Dental Technology Solutions from Advanced Automation 3A Networking Solutions Dental Practice Man 53647 3Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 1Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 2Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 3CMC Limited and FileVision LLC Announce Partnership to Provide Business Productivity Solutions to a Global Market 53637 1CMC Limited and FileVision LLC Announce Partnership to Provide Business Productivity Solutions to a Global Market 53637 2
...nted at 2007 APA Meeting -, COLLEGEVILLE, Pa., May... new studies examining safety and efficacy of,desv...euptake,inhibitor (SNRI) being studied as a potent...order (MDD), were presented today at the,2007 Amer... Diego,Calif., by Wyeth Pharmaceuticals, a divisi...
...dvance Clinical and Regulatory Development of Oral..., 2007 /PRNewswire-FirstCall/ -- Celgene,Corporati...of,leading oral anti-inflammatory candidates acros... (apremilast), an oral TNF,antagonist and anti-inf...ity and an excellent side effect profile in a plac...
Other Medicine Technology:New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 2Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 3Positive Clinical Data on CC-10004 Confirms Potential as Novel Oral,Approach to Treating Inflammatory Diseases 4
(Date:12/2/2009)...YORK, Dec. 2 Care Support of Amer...ation, Advanced Illness Coordinated Care (AICC) ,...last years of life as well as improve the quality ...thout increasing mortality. These are the principa...ournal of Managed Care (November 2009). ,, ...
(Date:12/2/2009)..., Dec. 2 TeamHealth ( www.teamheal... with the acquisition of Naples-based Emergency Ph..., EPN has held an exclusive contract with NCH Heal... the Downtown Naples Hospital, North Naples Hospit...ides the staffing for two stand-alone urgent care ...
(Date:12/2/2009)...o have a prostate-specific antigen (PSA) value of ...nal beam radiation therapy (EBRT) are less likely ...th, according to a study in the December 1 issue o...Biology*Physics, the official journal of the Ameri... levels in a prostate cancer patient are monitored...
(Date:12/2/2009)...ional Pen ( www.pens.com ), a worldwide leading pr... giving away 10,000 free business card pens. , ...National Pen ( www.pens.com ), a worldwide leading...is giving away 10,000 free business card pens. , ,...s that no other company in the industry can do, as...
(Date:12/2/2009)...ional Race Series to increase awareness of prostat... importance of early detection , ..., women, families, friends and neighbors – a...ipate in the Rudolph Ramble 5K. The Rudolph Rambl... which was launched by the Prostate Conditions Ed...
Breaking Medicine News(10 mins):Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:PACE Race Returns with Denver's Rudolph Ramble 2Health News:PACE Race Returns with Denver's Rudolph Ramble 3Health News:PACE Race Returns with Denver's Rudolph Ramble 4
...ompany to Debut ,Dog Gone Smart(TM) Wear Brand Dog... The Global Pet Expo February 14-16, SAN DIEGO, a... a Wilton, Connecticut-based company dedicated to ...for the first time in the U.S. at The Global Pet E...
... Even with effective anti-HIV therapies, doctors ...om infected individuals who are receiving such tre... in hideouts known as viral reservoirs. One import...+ T cells, are largely contained in lymph nodes an...
...awyer who brought the first federal case against J... trial, LOS ANGELES, Feb. 13 In the wake of Tu..., lawyer Ike Gulas prepares to take the,next major...sed law firm Gulas & Stuckey PC took the first,Dur...
... ATLANTA February 13, 2008 Eight outstanding can...nd regions have been chosen to receive the 2008 Am...e Award, a prestigious national prize for cancer c...ence in providing compassionate, skilled care, and...
...ORONA, Calif., Feb. 13 Watson,Pharmaceuticals, In...al,company, announced today that the U.S. Food and...ection of the company,s Florida facilities. No,inf...r Official Action Indicated ("OAI"). During that t...
...tudy found slowed information-processing, increase.... 13 (HealthDay News) -- Multiple sclerosis patien... are more likely to suffer cognitive shortfalls an...as is a rise in the rate of depression and anxiety...
Other Medicine News:Health News:Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today 2Health News:Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today 3Health News:Nano Pet Products, LLC Named Exclusive Worldwide Licensee by Schoeller(R) Technologies AG for Pet Products to Develop the Most Technologically Advanced Pet Brands on the Market Today 4Health News:HIV persists in the gut despite long-term HIV therapy 2Health News:Duragesic Trials Continue - Plaintiffs Optimistic After Latest Recall 2Health News:American Cancer Society honors exemplary cancer caregivers 2Health News:American Cancer Society honors exemplary cancer caregivers 3Health News:Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities 2Health News:Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems 2Health News:Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems 3
Retinal Angled Pick: 0.5mm 110 Tip Angle
Retinal Echart: 0.5mm, 45 Angle, Rounded Tip
Retinal Angled Spatula: Triangular 0.5mm Tip, 4.0mm Surface 150
Retinal Angled Spatula: Triangular 0.5mm Tip, 4.0mm Surface 110
Medicine Products: